ERBB2 and breast cancer: The authors developed 99mTc-radiolabeled silica NPs functionalized with a TZ half-chain and verified the nanoprobe specific affinity with SKBR-3 HER-2+ BC cells in vitro, and in the relative xenograft animal model ex vivo.